U.S. Water Utilities Stock News

NYSE:DAO
NYSE:DAOConsumer Services

Assessing Youdao (DAO) Valuation After The Launch Of Its Open-Source Lobster AI Agent

Why Youdao’s New AI Agent Matters for Investors Youdao (NYSE:DAO) has launched Youdao Lobster, described as China’s first fully open-source AI Agent, featuring a 5,000 plus skill store and integration with popular office messaging platforms. This launch highlights Youdao’s push into AI based tools and gives investors a fresh development to assess alongside the company’s existing learning services, smart devices, and online marketing businesses in China. See our latest analysis for...
NYSE:ATHM
NYSE:ATHMInteractive Media and Services

How Investors May Respond To Autohome (ATHM) Buybacks Amid Softer 2025 Earnings

Autohome Inc. recently reported fourth-quarter and full-year 2025 results showing lower revenue and net income year over year, while also confirming that it completed a prior buyback of 7,116,939 shares for US$184.50 million. On the same day, the Board authorized a new share repurchase program of up to US$200 million funded from existing cash, highlighting management’s continued focus on capital returns even as earnings softened. Now we’ll explore how the new US$200 million repurchase plan,...
NYSE:VIA
NYSE:VIASoftware

Via Transportation (VIA) Valuation Check After Recent Share Price Weakness

Recent price performance and business snapshot Via Transportation (VIA) has drawn attention after its share price declined about 7% over the past week and roughly 43% over the past 3 months, putting recent trading under closer investor review. The New York based transit software company reports annual revenue of US$434.3 million and a net loss of US$96.4 million. Its services span planning tools, operations software, and tech enabled transit solutions for public and private clients. See our...
NasdaqGS:CERT
NasdaqGS:CERTHealthcare Services

Assessing Certara (CERT) Valuation After FDA PBPK Milestone And New Biosimulation Software Launches

Certara (CERT) is back on investors’ radar after closing 2025 with revenue of US$418.8m, a small net loss, and fresh FDA validation of its biosimulation platform through PBPK modeling used in the asciminib NDA. See our latest analysis for Certara. Despite FDA validation for its PBPK work and new software launches, Certara’s share price has been under pressure, with a 90 day share price return of 23.91% and a 1 year total shareholder return of 39.10%. This may indicate fading momentum after...
NYSE:SVV
NYSE:SVVMultiline Retail

A Look At Savers Value Village (SVV) Valuation After Insider Trades And Strong Preliminary Q4 Sales

Savers Value Village (SVV) is back on investors’ radar after President and COO Jubran N. Tanious exercised options for 100,000 shares and sold 45,000 shares, along with preliminary fourth quarter comparable sales updates. See our latest analysis for Savers Value Village. At a share price of $7.88, Savers Value Village has a 1 day share price return of 1.03%, while the 30 day share price return of 30.20% and year to date share price return of 16.61% suggest recent momentum has faded. However,...
NasdaqGS:WDAY
NasdaqGS:WDAYSoftware

Workday And Insperity Target SMBs With Unified HRScale Platform Narrative

Workday (NasdaqGS:WDAY) and Insperity have introduced Insperity HRScale, a unified HR solution for small and mid sized businesses. The new offering combines payroll, compliance support, and workforce insights into a single package. Insperity HRScale integrates Insperity’s employer organization model with Workday’s human capital management technology. For investors watching NasdaqGS:WDAY, this move extends the company’s human capital management reach further into the small and mid sized...
NYSE:PSA
NYSE:PSASpecialized REITs

Public Storage Wells Data Partnership Refines Capital Allocation And Operations

Public Storage (NYSE:PSA) has entered a data science partnership with Welltower to refine capital allocation and operational analytics. The collaboration focuses on combining proprietary data and AI tools from both companies to inform investment and operating decisions. The move is intended to support Public Storage's long term value creation approach through more data driven decision making. For you as an investor, the interest here is how this data partnership might feed into the way...
NYSE:MAS
NYSE:MASBuilding

Is Masco (MAS) Now An Opportunity After Recent Share Price Weakness?

If you are wondering whether Masco's current share price offers good value or not, this article will walk you through what the numbers actually say about the stock. Masco recently closed at US$61.52, with returns of a 3.4% decline over 7 days, a 19.3% decline over 30 days, a 4.6% decline year to date, a 10.8% decline over 1 year, 31.6% over 3 years and 17.7% over 5 years. These moves may have changed how some investors view its potential and risk. Recent news around Masco has focused on its...
NYSE:GFF
NYSE:GFFBuilding

Clopay Award Puts Griffon’s Premium Housing Exposure And Valuation In Focus

Clopay Corporation, a wholly owned subsidiary of Griffon (NYSE:GFF), received the Best of IBS Award at the 2026 NAHB International Builders' Show. The award recognizes Clopay's Avante door with C-Power enabled Click-to-Conceal Panels as a development in garage door design and functionality. The recognition highlights Griffon's role in residential building products and adds recent company specific news that had not been widely discussed. For you as an investor looking at NYSE:GFF, this award...
NYSE:AZZ
NYSE:AZZBuilding

Is AZZ (AZZ) Share Price Justified After Recent Pullback And Multi Year Surge

If you are wondering whether AZZ is still reasonably priced after its run in recent years, this article will help you weigh what you are paying against what you might be getting. AZZ's share price closed at US$123.80, with a 0.2% slip over the last 7 days and an 11.7% decline over the last 30 days, set against a 12.8% year to date return and a 44.2% return over the past year. Those moves sit on top of multi year gains of 235.5% over 3 years and 148.0% over 5 years. This can change how...
NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

Assessing Immatics (IMTX) Valuation After Strong One Year Return And High Price To Sales Ratio

Immatics (IMTX) has been drawing attention after recent trading, with shares last closing at US$9.24. For investors, the key question is how this price lines up with the company’s fundamentals and risk profile. See our latest analysis for Immatics. That recent dip, with a 1-day share price return of a 1.81% decline and a 7-day share price return of a 6.29% decline, sits against a much stronger 1-year total shareholder return of 103.08%. This suggests longer term momentum has been positive...
NasdaqGS:INDB
NasdaqGS:INDBBanks

Independent Bank (INDB) Valuation Check After Recent Share Price Weakness And Acquisition Integration Plans

Why Independent Bank stock is on investors’ radar today Independent Bank (INDB) is drawing fresh attention after recent share performance, with a 1 day return of 0.45% contrasting with declines over the past week, month, and past 3 months. See our latest analysis for Independent Bank. At a share price of $74.74, Independent Bank has seen a recent 30 day share price return decline of 10.68%, but its 1 year total shareholder return of 21.57% suggests longer term holders have still been...
NasdaqGS:WLTH
NasdaqGS:WLTHCapital Markets

Wealthfront (WLTH) Valuation Check As Mixed Recent Returns Temper Earlier Share Price Strength

Event context for Wealthfront stock Wealthfront (WLTH) has drawn fresh attention after recent trading left the share price at US$7.86, with short term returns mixed and a value score of 4 prompting closer inspection from investors. See our latest analysis for Wealthfront. That recent 1 day share price return of 0.25% and 7 day share price return of 7.42% sit against a 90 day share price return of 43.66% and year to date share price return of 40.54%, suggesting momentum has been fading even...
NasdaqGS:FIZZ
NasdaqGS:FIZZBeverage

What National Beverage (FIZZ)'s Resilient EPS and Rising Shipments Mean for Shareholders

National Beverage Corp. recently reported past third-quarter results showing sales of US$264.59 million and net income of US$41.21 million, with basic and diluted earnings per share of US$0.44, slightly higher than a year earlier despite modestly lower revenue. The company also cited a 7% increase in January shipments and encouraging early fourth-quarter volume trends, suggesting that new product introductions and its decision not to fully pass through tariffs to consumers are helping...
NYSE:NATL
NYSE:NATLDiversified Financial

Assessing NCR Atleos (NATL) Valuation As Brink’s Deal Terms Highlight A Potential Pricing Gap

Recent performance snapshot for NCR Atleos (NATL) NCR Atleos (NATL) has drawn attention after recent trading, with the stock closing at $44.07 and showing mixed short term moves alongside stronger returns over the past 3 months and year to date. See our latest analysis for NCR Atleos. While the latest 1 day share price return of 0.54% and 7 day share price return of 3.06% are softer, the 30 day and 90 day share price returns of 4.33% and 14.65%, alongside a 1 year total shareholder return of...
NYSE:YOU
NYSE:YOUSoftware

Is It Too Late To Consider Clear Secure (YOU) After Its Recent 85% Share Price Jump?

If you are wondering whether Clear Secure is still interesting at current levels, the key question is how its market price compares with what the business might reasonably be worth. The stock last closed at US$44.63, with returns of 37.3% over the past 30 days and 85.6% over the past year, as well as a 103.3% return over three years, which many investors will see as a meaningful shift for both potential upside and risk. Recent attention on Clear Secure has focused on its role in security and...
NasdaqGS:STBA
NasdaqGS:STBABanks

Is S&T Bancorp (STBA) Pricing Look Attractive After Recent Share Price Pullback?

If you are wondering whether S&T Bancorp at around US$40.20 is offering fair value or a possible bargain, you are not alone, and this article is designed to help you frame that question clearly. The stock has seen mixed recent returns, with a 1.3% decline over the last week and an 8.0% decline over the last 30 days, set against gains of 2.4% year to date, 8.5% over 1 year, 38.6% over 3 years and 42.6% over 5 years. Recent attention on regional banks, along with continuing investor focus on...
NasdaqGS:SIRI
NasdaqGS:SIRIMedia

Is Sirius XM Holdings (SIRI) Pricing Reflect Long Term Share Price Declines And DCF Upside Potential

If you are wondering whether Sirius XM Holdings is still worth a place in your portfolio at today’s price, this article walks through what the current market valuation might be implying. The stock recently closed at US$21.99, with returns of 3.3% over the past 30 days, 7.2% year to date, 2.0% over the last year, and longer term 3 year and 5 year returns of 32.5% and 56.9% declines respectively. This tells a very different story depending on your time frame. Recent coverage has focused on...
NasdaqGS:TERN
NasdaqGS:TERNPharmaceuticals

Terns Pharmaceuticals (TERN) Is Up 8.6% After Pipeline Update And Index Inclusion News

Terns Pharmaceuticals recently attracted renewed attention after updating its corporate presentation with refreshed pipeline timelines and milestones, while also being selected for inclusion in a STOXX benchmark index effective March 23, 2026. This combination of clearer development visibility, impending index inclusion, and investor focus on the upcoming earnings update has sharpened debate around the company’s long-term prospects and current financial pressures. With investors now closely...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

Assessing MicroVision (MVIS) Valuation After Full Year Earnings Reveal Weaker Sales And Ongoing Losses

MicroVision’s latest earnings draw investor focus MicroVision (MVIS) is back in the spotlight after reporting full year 2025 earnings, with sales of US$1.21 million compared with US$4.7 million a year earlier and a net loss of US$94.98 million. See our latest analysis for MicroVision. Despite the earnings update, MicroVision’s share price has faced pressure, with a 30 day share price return of 29.18% and a 1 year total shareholder return of 58.42%. This suggests momentum has been fading as...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Time To Reassess Incyte (INCY) After Recent Share Price Pullback?

If you are wondering whether Incyte at around US$92.54 is offering good value or asking too much, you are not alone. This article is written for that exact question. The share price has seen mixed moves, with a 3.5% decline over the last 7 days and an 8.5% decline over the past month, alongside longer term returns of 36.4% over 1 year, 25.7% over 3 years and 16.6% over 5 years. Recent attention on Incyte has been shaped by ongoing product and pipeline updates, regulatory milestones and...
NasdaqGS:CDXS
NasdaqGS:CDXSLife Sciences

Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?

In March 2026, Codexis reported fourth-quarter 2025 results showing revenue of US$38.92 million and net income of US$9.6 million, reversing a prior-year loss and beating analyst expectations, alongside full-year 2025 revenue of US$70.39 million and guidance for 2026 revenue of US$72 million to US$76 million. The quarter was heavily influenced by a large technology transfer agreement with Merck and growing ECO Synthesis platform activity, which also underpins management’s view that existing...
NYSE:COF
NYSE:COFConsumer Finance

Is Capital One’s 360 Savings Settlement Reshaping the Investment Case For Capital One Financial (COF)?

In early March 2026, Capital One Financial agreed to a proposed class action settlement over its 360 Savings accounts, including a US$425.00 million Settlement Fund and a commitment to align future 360 Savings interest rates with its 360 Performance Savings product, subject to court approval. The case highlights how differences in interest paid on similar-looking products and alleged disclosure gaps can create substantial legal, financial, and reputational repercussions for a large consumer...
NasdaqGS:SHC
NasdaqGS:SHCLife Sciences

Why Sotera Health (SHC) Is Down 8.5% After a $382 Million Share Sale And What's Next

Sotera Health recently completed a follow-on equity offering of US$381.75 million, issuing 25,000,000 common shares at US$15.27 each, boosting its capital base but increasing its share count. This fresh equity capital gives Sotera Health more financial flexibility to fund growth projects or reduce debt, while shareholders weigh the impact of dilution. Next, we'll examine how this sizeable equity raise and resulting dilution could reshape Sotera Health's investment narrative going...